About Vitara Biomedical
Vitara Biomedical is a company based in Philadelphia (United States) founded in 1999. Vitara Biomedical has raised $124.99 million across 2 funding rounds from investors including Khosla Ventures, Sands Capital and Google Ventures. Vitara Biomedical offers products and services including Platform Therapy for Preterm Infants and Velocity TM pAVF System.
- Headquarter Philadelphia, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vitara Biomedical, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$124.99 M (USD)
in 2 rounds
-
Latest Funding Round
$50 M (USD), Series C
Oct 11, 2024
-
Investors
Khosla Ventures
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vitara Biomedical
Vitara Biomedical offers a comprehensive portfolio of products and services, including Platform Therapy for Preterm Infants and Velocity TM pAVF System.
Offers stable environment for premature babies to develop post-birth
Reduces reinterventions for fistula maturation in vascular procedures
People of Vitara Biomedical
Unlock access to complete
Funding Insights of Vitara Biomedical
Vitara Biomedical has successfully raised a total of $124.99M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vitara Biomedical
Vitara Biomedical has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Khosla Ventures, Sands Capital and Google Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate backed venture capital fund investing in multiple sectors
|
Locked | Locked | Locked | |
|
A venture capital fund focused on deep tech innovations is managed.
|
Locked | Locked | Locked | |
|
Flerie is engaged in investing in biotech and pharmaceutical companies.
|
Locked | Locked | Locked |
Investor details for Vitara Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vitara Biomedical
Investment portfolio details for Vitara Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vitara Biomedical
Detailed financials for Vitara Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vitara Biomedical Comparisons
Peer comparison for Vitara Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vitara Biomedical
Detailed competitors of Vitara Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vitara Biomedical
Complete news archive for Vitara Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vitara Biomedical
Vitara Biomedical was founded in 1999 and raised its 1st funding round 23 years after it was founded.
Vitara Biomedical is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
James S Mcglone is the current CEO of Vitara Biomedical.
Vitara Biomedical is a funded company, having raised a total of $124.99M across 2 funding rounds to date.
Vitara Biomedical was founded in 1999 and is headquartered in Philadelphia, United States. Operations focus on the biomedical sector, where neonatal care services are provided to support infant health. These services encompass medical and support interventions for newborns, primarily within the local and national geography. Leadership is held by CEO James S Mcglone, overseeing activities in this specialized field.
Vitara Biomedical offers Platform Therapy for Preterm Infants and Velocity TM pAVF System.
Vitara Biomedical has 5 investors. Key investors include Khosla Ventures, Sands Capital, Google Ventures, First Spark Ventures, and Flerie.